Carmat: Oddo maintains 'buy' recommendation

(CercleFinance.com) - Carmat has obtained the CE marking for its artificial heart, enabling the company to sell it in all the countries that recognise this certification.
Oddo considers this great news for the company and for the sector as a whole.

According to the analyst, Carmat should reach break-even at the end of 2025/beginning of 2026 and see its gross margins progressively improve, with an objective of 70%.

As a result, Oddo maintains its 'buy' recommendation on the Carmat share, with a price target of 27 euros.

Copyright (c) 2020 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.